QQ客服 官方微博 反馈留言

	Population pharmacokinetics and individualized lobaplatin regimen for the treatment of Chinese small cell lung cancer in the elderly
	Cheng Ying[1]; Wu Lin[2]; Liu Xiaoqing[3]; Zhao Yanqiu[4]; Liu Chunling[5]; Chen Qun[6]; Sun Tao[7]; Zheng Qingshan[8]
刊名	Medicine
	2019
卷号	98页码:e14136
ISSN号	1536-5964
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2164079
专题	上海大学
作者单位	1.[1]Jilin Cancer Hospital, Changchun. 2.[2]Hunan Cancer Hospital, Changsha. 3.[3]307 The 307th Hospital of PLA, Beijing. 4.[4]Henan Cancer Hospital, Zhengzhou. 5.[5]Affiliated Cancer Hospital of Xinjiang Medical University, Urumchi. 6.[6]Fuzhou Pulmonary Hospital of Fujian, Fuzhou. 7.[7]Liaoning Cancer Hospital, Shenyang. 8.[8]Clinical Research Centre of Shanghai University of Traditional Chinese Medicine, Shanghai, China.
推荐引用方式 GB/T 7714	Cheng Ying[1],Wu Lin[2],Liu Xiaoqing[3],et al. Population pharmacokinetics and individualized lobaplatin regimen for the treatment of Chinese small cell lung cancer in the elderly[J]. Medicine,2019,98:e14136.
APA	Cheng Ying[1].,Wu Lin[2].,Liu Xiaoqing[3].,Zhao Yanqiu[4].,Liu Chunling[5].,...&Zheng Qingshan[8].(2019).Population pharmacokinetics and individualized lobaplatin regimen for the treatment of Chinese small cell lung cancer in the elderly.Medicine,98,e14136.
MLA	Cheng Ying[1],et al."Population pharmacokinetics and individualized lobaplatin regimen for the treatment of Chinese small cell lung cancer in the elderly".Medicine 98(2019):e14136.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。